Leflunomide (Alembic Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Leflunomide drug offered from Alembic Pharmaceuticals Inc.. This Antirheumatic Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Alembic Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | Leflunomide |
SUBSTANCE NAME: | LEFLUNOMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antirheumatic Agent [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-12-01 |
END MARKETING DATE: | 0000-00-00 |
Leflunomide HUMAN PRESCRIPTION DRUG Details:
Item Description | Leflunomide from Alembic Pharmaceuticals Inc. |
LABELER NAME: | Alembic Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/1) |
START MARKETING DATE: | 2016-12-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 62332-061_a42c584c-b248-4335-a30b-0e8b61a27867 |
PRODUCT NDC: | 62332-061 |
APPLICATION NUMBER: | ANDA091369 |
Other LEFLUNOMIDE Pharmaceutical Manufacturers / Labelers: